Table 2 Demographic and clinical characteristics of patients with asthma and healthy controls

Number

12

4

Age in years, mean (SD)

50.1 (11.4)

54.3 (8.8)

Sex, male, n (%)

7 (58.3)

2 (50.0)

Disease duration in years, medium (range)

20.0 (0.5–59)

–

 Total eosinophil count (/μL), mean (SD)

340.0 (236.6)

124.8 (42.6)

 Total IgE (kU/L), mean (SD)

574.3 (1126.1)

15.5 (16.5)

 Specific anti-D. pteronyssinus IgE (kU/L), mean (SD)

11.1 (11.1)

0.09 (0.08)

 % of predicted FEV₁, mean (SD)

81.1 (14.9)

–

 % of predicted FEV₁/FVC, mean (SD)

69.7 (9.5)

–

 Bronchodilator, n (%)

12 (100.0)

–

 Leukotriene antagonist, n (%)

2 (16.7)

–

 Corticosteroid, n (%)

4 (33.3)

–

 Asthma Control Test score, mean (range)^a

18.3 (12–24)

–